TELA Bio (TELA) Shareholder's Equity (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.20 Mn |
| Dec 31, 2025 | 6.31 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 9.18 Mn |
| Mar 31, 2025 | 18.12 Mn |
| Dec 31, 2024 | 28.46 Mn |
| Sep 30, 2024 | -6.27 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 14.38 Mn |
| Dec 31, 2023 | 18.88 Mn |
| Sep 30, 2023 | 30.55 Mn |
| Jun 30, 2023 | 40.01 Mn |
| Mar 31, 2023 | 3.14 Mn |
| Dec 31, 2022 | 14.31 Mn |
| Sep 30, 2022 | 23.30 Mn |
| Jun 30, 2022 | -1.54 Mn |
| Mar 31, 2022 | 10.04 Mn |
| Dec 31, 2021 | 20.10 Mn |
| Sep 30, 2021 | 27.73 Mn |
| Jun 30, 2021 | 34.97 Mn |
| Mar 31, 2021 | 41.69 Mn |
| Dec 31, 2020 | 49.03 Mn |
| Sep 30, 2020 | 56.33 Mn |
| Jun 30, 2020 | 63.40 Mn |
| Mar 31, 2020 | 24.23 Mn |
| Dec 31, 2019 | 30.96 Mn |
| Sep 30, 2019 | -160.40 Mn |
| Jun 30, 2019 | -153.75 Mn |
| Mar 31, 2019 | -145.79 Mn |
| Dec 31, 2018 | -137.86 Mn |
| Sep 30, 2018 | -128.54 Mn |